2024

1. Alcohol Triggers the Accumulation of Oxidatively Damaged Proteins in Neuronal Cells and Tissues

   Antioxidants, Vol. 13, Núm. 5

2. Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus

   Lupus Science and Medicine, Vol. 11, Núm. 1

3. Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets

   Rheumatology (United Kingdom), Vol. 63, Núm. SI, pp. SI96-SI106

4. Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus

   Expert Review of Clinical Immunology, Vol. 20, Núm. 4, pp. 359-373

5. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

   Translational Psychiatry, Vol. 14, Núm. 1

6. Effects of cannabidiol in post-stroke mood disorders in neonatal rats

   Pediatric Research

7. Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands

   Bioorganic Chemistry, Vol. 142

8. G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits

   Nature communications, Vol. 15, Núm. 1, pp. 4307

9. High number of mitochondrial DNA alterations in postmortem brain tissue of patients with schizophrenia compared to healthy controls

   Psychiatry Research, Vol. 337

10. In need of a specific antibody against the oxytocin receptor for neuropsychiatric research: A KO validation study

    Journal of Psychiatric Research, Vol. 173, pp. 260-270

11. Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?

    Autoimmunity Reviews, Vol. 23, Núm. 1

12. Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain

    British Journal of Pharmacology

13. Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort

    Arthritis Care and Research

14. NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia

    Brain Structure and Function, Vol. 229, Núm. 5, pp. 1299-1315

15. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

16. Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome

    Biomedicines, Vol. 12, Núm. 1

17. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

    Seminars in Arthritis and Rheumatism, Vol. 66

18. Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 49, Núm. 1, pp. E35-E44

19. Proteina matrizelularren inplikazioa gaixotasun neuropsikiatrikoetan, hevin proteinan zentratuta

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 45, pp. 93-112

20. Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the Rheumatic Diseases